Faculty
Hani Ashamalla, MD, FCCP
Dr. Hani Ashamalla is the chairman of Radiation Oncology at NewYork-Presbyterian Brooklyn Methodist Hospital and clinical professor at Weill Cornell Medicine.
A graduate of Ain Shams University, Cairo Egypt in 1983, he spent three years as a pulmonology resident and was awarded a master’s degree in chest diseases after he presented his thesis on Short Term Treatment of Pulmonary Tuberculosis. He immigrated to the United States in 1989 and became a resident in the NY Methodist Hospital radiation oncology department in 1991. Upon graduation, he rotated at University of Pennsylvania for a pediatric oncology fellowship.
Upon graduation from fellowship, he became an assistant attending in the same department of radiation oncology and he progressed from that position until he became the chairman of radiation oncology at NewYork-Presbyterian Brooklyn Methodist Hospital in 2010. He is also the program director of a fully accredited radiation oncology residency program there.
Dr. Ashamalla is widely published, with over 100 peer-reviewed and nationally presented publications. His main work on the use of acupuncture to alleviate hot flashes in men with prostate cancer is commonly cited. He also has a special interest in the use of PET/CT scans in designing radiation plans.
Dr. Ashamalla is the principal investigator for the NRG national cooperative group at NewYork-Presbyterian Brooklyn Methodist Hospital.
He is a reviewer of the International Journal of Radiation Oncology - Biology - Physics, Technology at Cancer Research and Treatment Journal, Open Journal of Radiology (OJRAD) and Journal of Supportive Care in Cancer.
Dr. Ashamalla has been named a Top Doctor by Castle Connolly Medical since 2001, and in New York Magazine’s Best Doctors since 2011.
Onyinye Balogun, MD
Dr. Onyinye Balogun is an assistant professor of Radiation Oncology at Weill Cornell Medicine specializing in the treatment of breast and gynecologic malignancies. She is a graduate of Harvard University and Yale University School of Medicine. Dr. Balogun initiated her residency training at the University of Chicago and completed her final year at New York University.
Her research focuses on local and global disparities in cancer care and outcomes, particularly the delivery of radiation therapy in low and middle-income countries.
Bahaa Mokhtar, MD, MPH
Dr. Bahaa Mokhtar is an assistant clinical professor of Radiation Oncology at Weill Cornell Medicine and vice-chairman of the Department of Radiation Oncology at New York Presbyterian-Brooklyn Methodist Hospital where he also serves as the associate director of the residency program. Following a surgical oncology residency, Dr. Mokhtar went on to complete a radiation oncology residency at NewYork-Presbyterian Brooklyn Methodist.
He has been a member of the American Board of Radiation Oncology (99th percentile) since 1998. He has spent over 20 years as a radiation oncologist at NewYork-Presbyterian Brooklyn Methodist. He specializes in the treatment of Head and neck and Gynecological cancers using IMRT, Stereotactic Body radiotherapy (SBRT) among other advanced radiotherapy techniques.
Dr. Mokhtar is an excellent teacher and mentor for radiation oncology trainees and was named teacher of the year by AARO for several years. Dr. Mokhtar is a co-investigator in many of the NRG studies.
Himanshu Nagar, MD
Dr. Himanshu Nagar is a board certified radiation oncologist who specializes in caring for patients with genitourinary malignancies. Dr. Nagar received his undergraduate degree from Johns Hopkins University and his medical degree from the University of Texas Health Science Center at Houston. He completed his residency at NewYork-Presbyterian Hospital/Weill Cornell Medicine.
Dr. Nagar is the recipient of numerous honors, including the Physician of the Year Award from NewYork-Presbyterian Hospital along with multiple research grants, scholarships, and awards. Dr. Nagar uses the most advanced technology available for patients with prostate cancer including real-time MRI guidance and rectal spacer to deliver safer radiotherapy in as short as 5 visits.
He is actively involved in both translational and clinical research at Weill Cornell Medicine including several clinical trials. Dr. Nagar’s research is aimed at better defining and tailoring the role of radiotherapy for various genitourinary malignancies.